Welcome
Support Centre
09 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia (BPH).
ISRCTN ISRCTN53810731
ClinicalTrials.gov identifier
Public title Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia (BPH).
Scientific title
Acronym N/A
Serial number at source HTA 94/04/09
Study hypothesis Many of the newer means of treating symptomatic BPH require expensive new equipment which requires significant additional capital investment. We consider that before investing in such equipment we should evaluate cheaper electrosurgical methods which may be similarly efficacious.
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Urological and genital diseases: Other urological and genital disease
Participants - inclusion criteria 530 men with BPH causing bladder outflow obstruction will be recruited from four centres: one teaching hospital and three district general hospitals.
Participants - exclusion criteria Not provided at time of registration.
Anticipated start date 01/06/1996
Anticipated end date 31/12/2000
Status of trial Completed
Patient information material
Target number of participants 530
Interventions 1. Transurethral resection of the prostate (TURP)
2. Transurethral diathermy vaporisation of the prostate (TUDVP).
Perioperative complications and time to discharge, determined by strictly defined criteria will be compared.
Primary outcome measure(s) The efficacy of the operation will be assessed by symptom scores, urine flow rate studies at two months and one year after surgery. A questionnaire covering adverse events, quality of life, impact on sexual function and customer satisfaction will be administered preoperatively and at each visit by a trained nurse counsellor. This trial will be coordinated and the results analysed for safety, effectiveness and cost benefit in collaboration with the Prostate trials Office (PROTO) at Bristol.
Secondary outcome measure(s) Not provided at time of registration.
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15698525
Contact name Mr  Christopher  Fowler
  Address Academic Urological Unit
The Royal London Hospital
4th Floor
Alexandra Wing
Queen Mary and Westfield College
  City/town London
  Zip/Postcode E1 1BB
  Country United Kingdom
  Tel +44 (0)20 7377 7226
  Fax +44 (0)20 7377 8760
  Email C.G.Fowler@mds.qmw.ac.uk
Sponsor Department of Health (UK)
  Address Quarry House
Quarry Hill
  City/town Leeds
  Zip/Postcode LS2 7UE
  Country United Kingdom
  Email Sheila.Greener@doh.gsi.gov.uk
  Sponsor website: http://www.dh.gov.uk/en/index.htm
Date applied 25/04/2003
Last edited 15/01/2008
Date ISRCTN assigned 25/04/2003
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central